In human studies, components of the NLRP3 inflammasome are reported to be increased in RA PBMCs and ACPAs present in the sera of some RA patients can stimulate NLRP3-dependent IL-1β release [17, 31]. This evidence concerns the gene NLRP3 and rheumatoid arthritis.